Key Takeaways
- In 2024, Canada recorded nearly 60,000 hospitalizations for vaccine‑preventable respiratory illnesses, with influenza and RSV responsible for > 50 % and COVID‑19 contributing > 40 % of those admissions.
- The hospitalization rate rose to 142 per 100,000 Canadians in 2024, more than double the 66 per 100,000 observed in 2019.
- Average length of stay for a COVID‑19 admission is about 23 days, translating to an estimated cost of ≈ $28,500 per case.
- Vaccination coverage is declining: only 26 % of Canadian adults received a COVID‑19 vaccine in fall 2024 (seniors 65+ at 54 %), and just 33 % of adults were vaccinated against seasonal influenza for the 2024‑2025 season.
- Adults aged 75 years and older accounted for nearly 46 % of all vaccine‑preventable respiratory hospitalizations, underscoring the disproportionate burden on seniors.
- Hospitals are frequently operating at or over capacity, and experts warn that increasing staff and beds is a long‑term solution, making prevention through vaccination essential.
- Health leaders liken yearly vaccination to a seatbelt or insurance policy—a simple, low‑cost step that can prevent severe illness, long‑term care needs, and strain on the health‑care system.
Introduction and Overview of CIHI Findings
The Canadian Institute for Health Information (CIHI) released new data showing that vaccine‑preventable respiratory infections continue to place a substantial demand on Canada’s hospitals. In 2024, nearly 60,000 Canadians were admitted for conditions such as influenza, respiratory syncytial virus (RSV), and COVID‑19 that could have been mitigated through immunization. Influenza and RSV together made up more than half of these admissions, while COVID‑19 alone contributed over 40 %. CIHI director Melanie Josée Davidson emphasized that although the numbers are lower than the peak pandemic years, the ongoing impact remains “significantly more for our hospitals to handle.” This sets the stage for understanding why respiratory illnesses are still a pressing public‑health concern despite the waning acute phase of the pandemic.
Hospitalization Numbers and Trends
When expressed as a rate, the 2024 figure translates to 142 hospitalizations per 100,000 Canadians, a stark increase from 66 per 100,000 in 2019—more than a two‑fold rise over five years. The upward trend reflects not only the lingering presence of COVID‑19 but also the resurgence of seasonal influenza and RSV after periods of reduced circulation during pandemic‑related public‑health measures. Davidson noted that the current level, while below pandemic heights, represents a new baseline that the health system must accommodate year‑round. The data suggest that respiratory infections are no longer confined to a single “flu season” but can surge at various times, creating a persistent pressure on inpatient services.
Impact on Hospital Capacity and Costs
The strain on hospitals is evident in both occupancy levels and financial implications. Fahad Razak, an internal medicine physician at St. Michael’s Hospital, described seeing patients admitted for these illnesses as “one of the toughest parts of the job” and warned that hospital capacity issues are a “red flag.” He pointed out that expanding staff and adding beds are not instantaneous fixes; constructing a new hospital can take a decade from funding announcement to full operation. Consequently, the system must rely on optimizing existing resources. Moreover, the average length of stay for a COVID‑19 admission is approximately 23 days, leading to an estimated cost of $28,500 per hospitalization. These prolonged stays exacerbate bed shortages and drive up expenditures, limiting the ability to treat patients with non‑respiratory conditions.
Vaccination Coverage Gaps
Despite the clear benefits of immunization, vaccination rates are falling short of targets. Government of Canada figures indicate that only 26 % of Canadian adults received a COVID‑19 vaccine in the fall of 2024, with seniors aged 65 and older showing the highest coverage at 54 %. Seasonal influenza uptake is even lower, with just 33 % of adults vaccinated during the 2024‑2025 season. Natasha Crowcroft, vice‑president of infectious diseases and vaccination programs at the Public Health Agency of Canada, called this shortfall a signal that the public‑health system is not reaching enough people with the immunizations they need to stay healthy. The gap between available vaccines and actual administration leaves a sizable portion of the population vulnerable to severe respiratory illness.
Burden on Older Adults
Older individuals bear a disproportionate share of the hospitalization burden. Adults aged 75 years and older comprised almost 46 % of all vaccine‑preventable respiratory hospitalizations in 2024, a statistic Davidson highlighted as having “a very big impact on their health and their recuperation capacity.” Crowcroft stressed that protecting seniors is not only about vaccinating the elderly themselves but also about ensuring that those around them—family members, caregivers, and long‑term‑care staff—are immunized. This “cocooning” strategy reduces the likelihood of virus introduction into settings where older adults are most at risk of severe outcomes, including progression to long‑term care or increased mortality.
Perspectives from Health Experts
Experts consistently frame vaccination as a straightforward preventive measure akin to wearing a seatbelt. Razak noted that many hospitalized patients later express regret, saying they will “get my vaccine next year” after experiencing a severe bout of flu, COVID‑19, or RSV. He likened yearly vaccination to an insurance policy: “Getting your vaccine every year in the cycle just means there’s one less thing you have to worry about.” Crowcroft echoed this sentiment, urging health‑care providers and caregivers to view immunization as a protective layer for both individuals and the broader community. The consensus is that increasing vaccine uptake could substantially reduce hospital admissions, alleviate pressure on acute‑care services, and improve overall population health.
Broader Implications for the Health System
The convergence of high hospitalization rates, lingering COVID‑19 impacts, declining vaccine coverage, and capacity constraints creates a challenging environment for Canada’s health‑care system. When hospitals are filled with patients suffering from preventable respiratory illnesses, there is less room for individuals needing care for unrelated conditions—such as surgeries, chronic disease management, or emergency trauma care. Razak warned that “everything happens in that one place,” meaning a surge in respiratory cases can inadvertently delay or compromise treatment for other patients. The long‑term solution, therefore, hinges on two complementary strategies: sustaining investment in health‑human resources and infrastructure, and, crucially, boosting prevention through robust vaccination programs.
Conclusion and Call to Action
The CIHI data make clear that vaccine‑preventable respiratory diseases remain a significant driver of hospital utilization in Canada, with profound effects on older adults, system costs, and overall capacity. While building new hospitals and hiring more staff are necessary long‑term steps, they cannot address the immediate pressure caused by avoidable admissions. Increasing vaccination rates—particularly for COVID‑19, influenza, and RSV—offers a rapid, cost‑effective means to reduce severe illness, shorten hospital stays, and protect vulnerable populations. Public‑health officials, clinicians, and community leaders must collaborate to improve outreach, counter vaccine hesitancy, and reinforce the message that yearly immunization is a simple, powerful tool akin to a seatbelt: it protects the individual and, by extension, the entire health‑care system. By acting now, Canada can alleviate current strain and build a more resilient foundation for future respiratory illness seasons.